Skip to main content
NCBI home page
Molecular Pathology : MP logoLink to Molecular Pathology : MP
. 1998 Apr;51(2):105–109. doi: 10.1136/mp.51.2.105

Improved diagnosis of reactivated toxoplasmosis.

D Ashburn 1, M M Davidson 1, A W Joss 1, T H Pennington 1, D O Ho-Yen 1
PMCID: PMC395619  PMID: 9713595

Abstract

AIMS: To identify antigens detected by western blotting in primary Toxoplasma gondii infection and determine their role in diagnosis of reactivated toxoplasmosis. METHODS: Twenty three immunocompromised patients were tested by IgG western blotting. Patients were grouped retrospectively. Group 1 comprised 15 human immunodeficiency (HIV)/AIDS patients and included: group 1A (six patients with clinical and/or serological evidence of reactivation), group 1B (five patients with clinical evidence only), and group 1C (four asymptomatic patients). Group 2 comprised eight non-HIV/AIDS immunocompromised patients with clinical and/or serological evidence of reactivation. Immunocompetent patients (n = 23) with primary toxoplasmosis were a control group used to determine the progression of the antigens detected. RESULTS: In primary toxoplasmosis, antibodies against 6, 20, 22, 23, 25, 28, 29, and 36 kDa antigens predominated. Detection of four or more of the 6, 20, 22, 23, 25, and 36 kDa antigens was considered to be western blot positive. In two group 1A patients, western blotting indicated past infection. During reactivation, this reverted to being western blot positive. Three other group 1A patients were western blot positive. In three of five group 1B patients, western blot positive results improved serological diagnosis of reactivated toxoplasmosis (p < 0.05). In two of five group 1B patients and all four group 1C patients, western blot indicated past infection. In group 2, two of eight patients reverted from a pattern of past infection to western blot positive. Five other patients from group 2 were western blot positive. CONCLUSIONS: Detection of some low molecular weight antigens is diagnostic of reactivated toxoplasmosis. These antigens can be detected even with normal dye test titres and their detection improves the diagnosis of reactivated toxoplasmosis. They might be the result of the release of bradyzoites from ruptured tissue cysts.

Full Text

The Full Text of this article is available as a PDF (140.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Erlich H. A., Rodgers G., Vaillancourt P., Araujo F. G., Remington J. S. Identification of an antigen-specific immunoglobulin M antibody associated with acute Toxoplasma infection. Infect Immun. 1983 Aug;41(2):683–690. doi: 10.1128/iai.41.2.683-690.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hassl A., Aspöck H. Antigens of Toxoplasma gondii recognized by sera of AIDS patients before, during, and after clinically important infections. Zentralbl Bakteriol. 1990 Apr;272(4):514–525. doi: 10.1016/s0934-8840(11)80053-8. [DOI] [PubMed] [Google Scholar]
  3. Hassl A., Aspöck H., Flamm H. Circulating antigen of Toxoplasma gondii in patients with AIDS: significance of detection and structural properties. Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Nov;270(1-2):302–309. doi: 10.1016/s0176-6724(88)80167-6. [DOI] [PubMed] [Google Scholar]
  4. Hellerbrand C., Goebel F. D., Disko R. High predictive value of Toxoplasma gondii IgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis. Eur J Clin Microbiol Infect Dis. 1996 Nov;15(11):869–872. doi: 10.1007/BF01691219. [DOI] [PubMed] [Google Scholar]
  5. Ho-Yen D. O., Joss A. W., Balfour A. H., Smyth E. T., Baird D., Chatterton J. M. Use of the polymerase chain reaction to detect Toxoplasma gondii in human blood samples. J Clin Pathol. 1992 Oct;45(10):910–913. doi: 10.1136/jcp.45.10.910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Israelski D. M., Remington J. S. Toxoplasmic encephalitis in patients with AIDS. Infect Dis Clin North Am. 1988 Jun;2(2):429–445. [PubMed] [Google Scholar]
  7. Israelski D. M., Remington J. S. Toxoplasmosis in patients with cancer. Clin Infect Dis. 1993 Nov;17 (Suppl 2):S423–S435. doi: 10.1093/clinids/17.supplement_2.s423. [DOI] [PubMed] [Google Scholar]
  8. Israelski D. M., Remington J. S. Toxoplasmosis in the non-AIDS immunocompromised host. Curr Clin Top Infect Dis. 1993;13:322–356. [PubMed] [Google Scholar]
  9. Joss A. W., Skinner L. J., Chatterton J. M., Cubie H. A., Pryde J. F., Campbell J. D. Toxoplasmosis: effectiveness of enzyme immunoassay screening. Med Lab Sci. 1989 Apr;46(2):107–112. [PubMed] [Google Scholar]
  10. Joss A. W., Skinner L. J., Moir I. L., Chatterton J. M., Williams H., Ho-Yen D. O. Biotin-labelled antigen screening test for toxoplasma IgM antibody. J Clin Pathol. 1989 Feb;42(2):206–209. doi: 10.1136/jcp.42.2.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  12. Luft B. J., Remington J. S. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992 Aug;15(2):211–222. doi: 10.1093/clinids/15.2.211. [DOI] [PubMed] [Google Scholar]
  13. Moir I. L., Davidson M. M., Ho-Yen D. O. Comparison of IgG antibody profiles by immunoblotting in patients with acute and previous Toxoplasma gondii infection. J Clin Pathol. 1991 Jul;44(7):569–572. doi: 10.1136/jcp.44.7.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pinon J. M., Foudrinier F., Mougeot G., Marx C., Aubert D., Toupance O., Niel G., Danis M., Camerlynck P., Remy G. Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients. J Clin Microbiol. 1995 Apr;33(4):878–884. doi: 10.1128/jcm.33.4.878-884.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Potasman I., Araujo F. G., Desmonts G., Remington J. S. Analysis of Toxoplasma gondii antigens recognized by human sera obtained before and after acute infection. J Infect Dis. 1986 Oct;154(4):650–657. doi: 10.1093/infdis/154.4.650. [DOI] [PubMed] [Google Scholar]
  16. Ruskin J., Remington J. S. Toxoplasmosis in the compromised host. Ann Intern Med. 1976 Feb;84(2):193–199. doi: 10.7326/0003-4819-84-2-193. [DOI] [PubMed] [Google Scholar]
  17. Sharma S. D., Mullenax J., Araujo F. G., Erlich H. A., Remington J. S. Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol. 1983 Aug;131(2):977–983. [PubMed] [Google Scholar]
  18. Tomavo S., Fortier B., Soete M., Ansel C., Camus D., Dubremetz J. F. Characterization of bradyzoite-specific antigens of Toxoplasma gondii. Infect Immun. 1991 Oct;59(10):3750–3753. doi: 10.1128/iai.59.10.3750-3753.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Verhofstede C., Van Gelder P., Rabaey M. The infection-stage-related IgG response to Toxoplasma gondii studied by immunoblotting. Parasitol Res. 1988;74(6):516–520. doi: 10.1007/BF00531628. [DOI] [PubMed] [Google Scholar]
  20. Weiss L. M., Udem S. A., Tanowitz H., Wittner M. Western blot analysis of the antibody response of patients with AIDS and toxoplasma encephalitis: antigenic diversity among Toxoplasma strains. J Infect Dis. 1988 Jan;157(1):7–13. doi: 10.1093/infdis/157.1.7. [DOI] [PubMed] [Google Scholar]
  21. Williams K. A., Scott J. M., Macfarlane D. E., Williamson J. M., Elias-Jones T. F., Williams H. Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect. 1981 Sep;3(3):219–229. doi: 10.1016/s0163-4453(81)90773-8. [DOI] [PubMed] [Google Scholar]
  22. Wong S. Y., Remington J. S. Biology of Toxoplasma gondii. AIDS. 1993 Mar;7(3):299–316. doi: 10.1097/00002030-199303000-00001. [DOI] [PubMed] [Google Scholar]
  23. Woodison G., Balfour A. H., Smith J. E. Sequential reactivity of serum against cyst antigens in Toxoplasma infection. J Clin Pathol. 1993 Jun;46(6):548–550. doi: 10.1136/jcp.46.6.548. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES